©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114378
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114378
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114378
Table 1 Comparison of the baseline demographics for the study cohorts
| Data | Synchronous group (n = 56) | Sequential group (n = 50) | χ2/t | P value |
| Sex (male/female) | 32/24 | 28/22 | 0.014 | 0.906 |
| Age (years) | 60.12 ± 5.94 | 59.82 ± 6.94 | 0.240 | 0.811 |
| Child-Pugh classification (A/B) | 30/26 | 30/20 | 0.444 | 0.505 |
| Tumor diameter (cm) | 4.48 ± 0.80 | 4.40 ± 0.91 | 0.482 | 0.631 |
| Clinical staging (II/III/IV) | 18/26/12 | 13/27/10 | 0.670 | 0.716 |
| Number of lesions (single/multiple) | 19/37 | 20/30 | 0.419 | 0.518 |
- Citation: Yu Y, Yuan W, Lei J, Zhao CB, Tao CG, Liu SH, Wang BL. Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. World J Gastrointest Surg 2026; 18(2): 114378
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114378.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114378